TRIUMPH-1 enrolled approximately 2,300 patients and is expected to complete around mid-year
Shcherban, O., & Dzhus, I
These results, however, must be taken into careful consideration, mainly because of a small number of analyzed clinical studies and high between-study heterogeneity [120]
Ilyas A, Wijayasinghe YS, Khan I, el Samaloty NM, Adnan M, Dar TA, Poddar NK, Singh LR, Sharma H, Khan S
Where Does GLP-1 Fit In
67 Other cell lines that have demonstrated NBDHEX sensitivity include Ewing sarcoma, 68 the human mesothelioma cell lines MPP89, MMB1, MSTO211H, and Mero48a, 69 melanoma cell lines Me501 and A375, 42 and the non-small-cell lung cancer cell line H69AR